Kumarasamy N - Search Results

1

Adverse effects of highly active antiretroviral therapy in developing countries.

Subbaraman R, Chaguturu SK, Mayer KH, Flanigan TP, Kumarasamy N. Subbaraman R, et al. Among authors: kumarasamy n. Clin Infect Dis. 2007 Oct 15;45(8):1093-101. doi: 10.1086/521150. Epub 2007 Sep 6. Clin Infect Dis. 2007. PMID: 17879931 Review.

2

The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India.

Kumarasamy N, Solomon S, Chaguturu SK, Mahajan AP, Flanigan TP, Balakrishnan P, Mayer KH. Kumarasamy N, et al. AIDS. 2003 Oct 17;17(15):2267-9. doi: 10.1097/00002030-200310170-00019. AIDS. 2003. PMID: 14523288

3

A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy.

Vallabhaneni S, Kumarasamy N, Wing EJ, Flanigan TP. Vallabhaneni S, et al. Among authors: kumarasamy n. AIDS Read. 2005 Feb;15(2):72-5. AIDS Read. 2005. PMID: 15712396

4

Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients.

Kumarasamy N, Vallabhaneni S, Flanigan TP, Balakrishnan P, Cecelia A, Carpenter CC, Solomon S, Mayer KH. Kumarasamy N, et al. AIDS. 2005 Mar 24;19(6):625-7. doi: 10.1097/01.aids.0000163940.85940.03. AIDS. 2005. PMID: 15802982

5

Low-cost monitoring of HIV infected individuals on highly active antiretroviral therapy (HAART) in developing countries.

Balakrishnan P, Solomon S, Kumarasamy N, Mayer KH. Balakrishnan P, et al. Among authors: kumarasamy n. Indian J Med Res. 2005 Apr;121(4):345-55. Indian J Med Res. 2005. PMID: 15817948 Review.

6

HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India.

Balakrishnan P, Kumarasamy N, Kantor R, Solomon S, Vidya S, Mayer KH, Newstein M, Thyagarajan SP, Katzenstein D, Ramratnam B. Balakrishnan P, et al. Among authors: kumarasamy n. AIDS Res Hum Retroviruses. 2005 Apr;21(4):301-5. doi: 10.1089/aid.2005.21.301. AIDS Res Hum Retroviruses. 2005. PMID: 15943572

7

Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India.

Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, Flanigan TP, Carpenter CC, Solomon S, Mayer KH. Kumarasamy N, et al. J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):53-8. doi: 10.1097/01.qai.0000188123.15493.43. J Acquir Immune Defic Syndr. 2006. PMID: 16340473

8

Bacterial vaginosis in female sex workers in Chennai, India.

Uma S, Balakrishnan P, Murugavel KG, Srikrishnan AK, Kumarasamy N, Cecelia JA, Anand S, Mayer KH, Celentano D, Thyagarajan SP, Solomon S. Uma S, et al. Among authors: kumarasamy n. Sex Health. 2005;2(4):261-2. doi: 10.1071/sh05025. Sex Health. 2005. PMID: 16402677

9

A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings.

Balakrishnan P, Solomon S, Mohanakrishnan J, Cecelia AJ, Kumarasamy N, Murugavel KG, Venkatakrishnan B, Solomon SS, Crowe SM, Ganesh AK, Thyagarajan SP, Flanigan T, Mayer KH. Balakrishnan P, et al. Among authors: kumarasamy n. J Acquir Immune Defic Syndr. 2006 Sep;43(1):23-6. doi: 10.1097/01.qai.0000227791.92203.d5. J Acquir Immune Defic Syndr. 2006. PMID: 16885780

10

Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.

Freedberg KA, Kumarasamy N, Losina E, Cecelia AJ, Scott CA, Divi N, Flanigan TP, Lu Z, Weinstein MC, Wang B, Ganesh AK, Bender MA, Mayer KH, Walensky RP. Freedberg KA, et al. Among authors: kumarasamy n. AIDS. 2007 Jul;21 Suppl 4(Suppl 4):S117-28. doi: 10.1097/01.aids.0000279714.60935.a2. AIDS. 2007. PMID: 17620747 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page